Avalyn Pharma

Avalyn Pharma is a clinical-stage biopharmaceutical company focused on developing inhaled therapies to treat rare respiratory diseases, particularly interstitial lung diseases (ILDs) like pulmonary fibrosis. Their lead candidate, AP01, an inhaled formulation of pirfenidone, is currently in a Phase 2b study and has demonstrated clinical proof-of-concept with improved efficacy and safety compared to existing oral therapies. Avalyn aims to provide a safer and more effective treatment option for patients with ILDs by delivering medication directly to the site of disease, reducing systemic exposure and associated side effects.

Avalyn emphasizes a patient-centric approach, building a culture that encourages collaboration, innovation, and professional development. The company offers a competitive compensation and benefits package including stock options, flexible schedules, remote work, and a commitment to work-life integration. Their mission is to enhance the lives of patients by developing innovative inhaled therapies that address unmet needs in the treatment of rare respiratory diseases.

Avalyn Pharma offers flexible schedules and remote work opportunities to its employees, demonstrating a commitment to work-life integration. This is reflected in their benefits package, which includes a wellness program and generous time off for vacation, personal needs, and volunteer work.

Avalyn Pharma offers a competitive total rewards package, including competitive salaries with an all-employee bonus program, long-term incentives for all employees including a stock options plan, comprehensive benefits coverage for domestic partners, flexible schedules and remote work options, a wellness program, generous vacation and personal time off, parking/transit reimbursement, and opportunities for professional growth.

Avalyn Pharma is a clinical-stage biopharmaceutical company dedicated to enhancing the lives of patients suffering from rare respiratory diseases. They develop innovative inhaled therapies that address unmet needs in this area, with a particular focus on treating Interstitial Lung Diseases (ILD), including Pulmonary Fibrosis. Their mission is to be the leader in bringing inhaled innovation to rare lung diseases, improving patient outcomes and quality of life.

Avalyn Pharma promotes a collaborative, innovative, and supportive culture. They are a spunky, entrepreneurial start-up focused on rare lung diseases with employees who are passionate about helping patients. The company encourages open communication, creative thinking, and professional development, creating an empowering work environment where people enjoy coming to work.

Avalyn Pharma is committed to fostering a diverse, equitable, and inclusive workplace that values the unique perspectives and contributions of all employees. Their commitment to diversity, equity, and inclusion is reflected in their benefits and perks, which include competitive salaries, a stock options plan, comprehensive benefits coverage for domestic partners, flexible schedules, remote work options, and a wellness program. Avalyn believes that a diverse workforce is essential to their success and they strive to create a culture of respect and inclusion where everyone feels valued and empowered.